Physician
Cheyenne County Hospital Association INC
Cheyenne County Hospital Association INC was paid $3.76M by Medicaid between Jan 2018 and Dec 2024, across 82 billing codes. Its largest line is 99283, emergency room visit (moderate) — 24% of everything it billed.
33Billing provider infoCHEYENNE COUNTY HOSPITAL ASSOCIATION INC
SIDNEY, NE 69162
SIDNEY, NE 69162
33aNPI1487736963assigned 10/20/2006
33bProvider typeEmergency Medicine Physician
28Total paid$3.76M
24GClaims63,002
24DCodes billed82
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Medicine Physician providers in Nebraska
Rank by total paid#6 of 22
Median peer was paid$109K
This provider vs. median35×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,352 | $528K | |
| 2019 | 8,886 | $437K | |
| 2020 | 7,753 | $413K | |
| 2021 | 15,086 | $939K | |
| 2022 | 12,579 | $822K | |
| 2023 | 5,330 | $379K | |
| 2024incomplete | 3,016 | $241K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 24% | 6,823 | 5,344 | $896K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 12% | 6,195 | 1,625 | $463K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 1,333 | 1,140 | $455K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.2% | 536 | 413 | $234K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4.5% | 1,910 | 592 | $171K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.3% | 4,589 | 4,084 | $162K |
| 80053 | Comprehensive metabolic panel | 3.9% | 4,118 | 3,438 | $146K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.5% | 731 | 702 | $133K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.0% | 3,819 | 3,695 | $112K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.3% | 878 | 706 | $85K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.1% | 3,097 | 2,534 | $78K |
| J3490 | Unclassified drugs | 2.0% | 3,605 | 1,669 | $74K |
70 more codes
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2.0% | 622 | $73K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 3,181 | $68K |
| 36415 | Collection of venous blood by venipuncture | 1.6% | 6,020 | $59K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 308 | $35K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,044 | $33K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 250 | $30K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 302 | $29K |
| 87631 | <1% | 357 | $26K | |
| 85027 | <1% | 1,452 | $25K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 218 | $25K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 15 | $24K |
| 87088 | <1% | 874 | $22K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 233 | $21K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 405 | $20K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 212 | $17K |
| 81003 | <1% | 1,284 | $17K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 317 | $16K |
| 81001 | <1% | 995 | $12K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 81 | $12K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 148 | $11K |
| 84484 | <1% | 249 | $11K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 343 | $10K |
| 80061 | Lipid panel | <1% | 279 | $10K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 217 | $10K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 81 | $9K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 133 | $9K |
| 71045 | Radiologic examination, chest; single view | <1% | 75 | $7K |
| 83735 | <1% | 558 | $7K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 193 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 271 | $7K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 96 | $7K |
| 86140 | <1% | 162 | $6K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 144 | $6K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 54 | $5K |
| 81025 | <1% | 139 | $5K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 888 | $4K |
| 80306 | <1% | 42 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 85 | $4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 182 | $4K |
| 84145 | <1% | 85 | $4K | |
| 97161 | <1% | 55 | $3K | |
| A9270 | Non-covered item or service | <1% | 251 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 48 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 48 | $3K |
| 97164 | <1% | 74 | $2K | |
| 90686 | <1% | 276 | $2K | |
| J2704 | Injection, propofol, 10 mg | <1% | 340 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 41 | $2K |
| 97168 | <1% | 40 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 338 | $2K |
| 87400 | <1% | 16 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 442 | $2K |
| 84439 | <1% | 43 | $1K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 15 | $1K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 14 | $1K |
| 87077 | <1% | 66 | $1K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 31 | $1K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 12 | $1K |
| 87186 | <1% | 49 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 241 | $870.89 |
| 83690 | <1% | 15 | $740.74 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 48 | $728.34 |
| Q3014 | Telehealth originating site facility fee | <1% | 13 | $318.85 |
| 90656 | <1% | 16 | $233.40 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 28 | $232.25 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 27 | $144.71 |
| 90685 | <1% | 13 | $139.23 | |
| 90670 | <1% | 13 | $131.04 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 33 | $129.92 |
| G0008 | Administration of influenza virus vaccine | 0% | 128 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialUTLEY, KELLY (CFO)
| Provider | Location | Paid |
|---|---|---|
| Cheyenne County Hospital Association INC | Sidney, NE | $1.33M |
| Cheyenne County Hospital Association INC | Sidney, NE | $1.24M |
| Cheyenne County Hospital Association, INC. | Sidney, NE | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.